Welcome to our dedicated page for Telus SEC filings (Ticker: TU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The TELUS Corporation (TU) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, primarily filed on Form 6‑K under the Securities Exchange Act of 1934. As a foreign private issuer, TELUS uses Form 40‑F for its annual reporting framework and furnishes interim information, press releases, financing documents and indentures through 6‑K submissions. These filings often incorporate documents by reference into the company’s Form F‑10 shelf registration statement for securities offerings.
Recent TELUS 6‑K filings include press releases on topics such as the engagement of financial advisors for the TELUS Health monetisation strategy, leadership share purchases, the redemption of specific note series, and the results of cash tender offers for multiple series of debt securities. Other 6‑Ks provide key transaction documents, including underwriting agreements, agency agreements and supplemental indentures related to U.S. and Canadian fixed‑to‑fixed rate junior subordinated notes offerings.
For investors, these filings are a primary source for understanding TELUS’ capital structure, debt profile and funding activities, as well as updates to its deleveraging and capital allocation plans. They also document dividend‑related communications and mid‑term outlook statements that the company furnishes to the market. Because TELUS files under the Form 40‑F regime, its annual information and financial statements are linked to Canadian regulatory filings, while the 6‑Ks ensure that key developments are available through the SEC’s EDGAR system.
On Stock Titan, each TELUS filing is accompanied by AI‑powered summaries designed to highlight the main points of lengthy documents, such as financing terms, redemption provisions or material strategic announcements. Users can quickly scan new Form 6‑K submissions, review referenced exhibits like press releases and indentures, and monitor how TELUS’ regulatory disclosures align with its stated strategy in areas such as TELUS Health, TELUS Digital and debt management.
TELUS Corporation submitted a Form 6-K as a foreign private issuer for December 2025. The filing primarily makes several supplemental indentures and a closing press release part of the U.S. public record and incorporates two of these exhibits by reference into TELUS’s existing Form F-10 shelf registration statement (File No. 333-291929). The exhibits listed include the Eleventh and Twelfth Supplemental Indentures, a closing press release dated December 9, 2025, and the Fifty-Sixth and Fifty-Seventh Series Supplemental Indentures, each dated December 9, 2025.
FAQ
What is the current stock price of Telus (TU)?
What is the market cap of Telus (TU)?
